Litegrav

Microgravity and other extreme environments represent unexplored frontiers for biotechnology and regenerative medicine, and the ability to systematically test and optimize biological processes under these conditions has the potential to redefine industries. Litegrav has developed a system to do this on the ground at high throughput and high content, partnering with stakeholders from academia, biotech and pharma for platform usage and co-development of assets, particularly in models of aging, cell stage and morphology tuning (including 3D tumor and stem cells), and microorganisms.